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Background: Declining immune function poses an important clinical challenge worldwide and supplementation
with natural products that possessing immune enhancing properties is a promising approach for preventing or
delaying immune function decline. Cocoons from yellow silkworms are a significant source of lutein, and this
unexplored silk extract could be a viable alternative source for dietary lutein. This study assessed immunomodulatory
activities of the silk lutein extract. Female BALB/c mice orally received lutein, either as silk or marigold extracts (10 or 20 mg/kg
daily), or vehicle only (1% tween 80 in PBS pH 7.4) for 4 weeks. Natural killer (NK) cell activity, specific antibody production,
lymphocyte subpopulations, mitogen-induced lymphocyte proliferation, and cytokine production were examined.
Results: Silk lutein extract increased NK cell activity, and the effect was dose-related whereas marigold lutein extract
was ineffective. Silk lutein extract dose-dependently enhanced antibody production in pre-immunized mice but marigold
lutein extract had no effect. Feeding with silk lutein extract increased the populations of CD3+ and CD4 + CD3 + cells. Silk
lutein extract also stimulated concanavalin A- and lipopolysaccharide-induced proliferations of T and B lymphocytes,
respectively. Moreover, silk lutein extract increased IL-2 and IFN-γ production while the effect of marigold lutein extract
was undetectable.
Conclusions: Together, silk lutein extract enhanced both innate and adaptive immune functions. This preparation may
prove to be an effective supplement for strengthened immunity.
Keywords: Antibody production, BALB/c mice, Immune function, Interleukin-2, Natural killer cells, Silk lutein extractBackground
Immune functions are indispensable as they are the host
defenses against infections and cancers, and therefore
play a crucial role in maintaining health. Declining immune
functions that occur as a result of aging, chronic illnesses,
physical and mental stress or unhealthy lifestyles is a major
clinical problem globally. Supplementing the immune sys-
tem with natural products that possess immune enhancing
activities is a promising approach for preventing decline of
immune functions. Nonprovitamin A carotenoids, notably
lutein, have attracted great interest over the decades [1]. The
xanthophyll lutein has been noted for its importance in
preventing age-related macular degeneration [2-4], cataracts
[5], UV-induced skin damage [6], and tumor growth [7-9].
Accumulated evidence to date has also interestingly* Correspondence: kunthalertd@yahoo.com
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unless otherwise stated.indicated that lutein has a role in regulating immune
functions [1]. For instance, it increases phytohemagglutinin
(PHA)-stimulated lymphocyte proliferation [8] and
enhances antibody production in response to T-dependent
antigen in murine spleen cells [10]. Studies that used
animals, which are inefficient converters of carotenoids
to vitamin A, also supported the immune regulating
role of lutein [11,12]. Dietary lutein supplementation
has been shown to stimulate both humoral and cellular
immunity in cats, dogs as well as zebra finches [11-13].
The use of lutein has been increasingly recommended
by some physicians as well as more generally used by
the public as a dietary supplement [14-16].
Human cannot synthesize lutein and uptake is therefore
dependent on the consumption of diet including certain
fruits, leafy green vegetables and egg yolks [17]. Lutein
used in most studies as well as that contained in most
commercial dietary supplements is obtained from marigold
flowers. Alternative sources of lutein have, however,
continuously been investigated [18,19]. Yellow cocoons ofral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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on the grounds of studies that reported to contain a
significant amount of the carotenoid pigments [20]. Up to
88% of carotenoids in yellow silk cocoons is the xanthophyll
lutein [21]. Providing that, the silk lutein extract from
yellow cocoons could alternatively become a valuable
dietary resource and may expand uses of lutein in the field
of medicine, especially in immune modulating therapies.
The present study was therefore designed to investigate
the effects of such yellow silk lutein extract in modulating
immune functions that require both innate and adaptive
systems to work in concert. The effects of an equivalent
content of lutein derived from marigold extract were also
examined. While previous research showed actions only on
the adaptive arm, this study also examined innate immune
responses to silk lutein extract, and it was found that there was
selectively increased NK cell and Tand B lymphocyte activities.
Results
Body weights, and spleen and thymus indices
Daily oral administration of lutein extracts either from
silk cocoons or from marigolds produced no signs of
ill-health (behavior, body coat, feces, etc.), no mortalities,
and no differences in body weights. In addition, there were
no differences in the spleen and thymus indices between
the control and treatment groups throughout the study
(data not shown).
Effect on natural killer cell activity
The oral administration of silk lutein extract (10 and 20 mg/
kg) for 2 weeks clearly increased (P < 0.01) the activity of
NK cells, and these effects appeared to be dose related as
demonstrated in Figure 1. In contrast, none of the samples
from the animals treated with marigold lutein extract
appeared to show any change.
Effect on splenic lymphocyte subpopulations
Alterations in the percentages of lymphocyte subsets
were observed after lutein extract administration and
illustrated in Figure 2. Oral administration of silk lutein
extract consecutively for 4 weeks did not influence the
percentages of CD21/35+ B cells and CD8 +CD3 +T
cytotoxic (Tc) (Figure 2A and 2D). However, significant
increases in the percentage of CD3+ total T cells (P < 0.05)
and CD4+CD3+T helper (Th) cells (P < 0.01) were detected
in mice fed 20 mg/kg silk lutein extract compared to the
control (Figure 2B and 2C). In contrast, mice in the marigold
lutein extract treated groups did not show any differences in
total T and Th populations throughout the 4-week period
and this have previously been described elsewhere [22].
Effect on mitogen-induced lymphocyte proliferation
Silk lutein extract (10 and 20 mg/kg) significantly
enhanced the ConA-induced proliferative response ofsplenic lymphocytes, but this did not appear to be dose
related (Figure 3A). Marigold lutein extract (20 mg/kg)
also showed such proliferative effects. For LPS (2.5 μg/ml) as
the challenge, increased (P < 0.05) lymphocyte proliferative
responses were observed in mice fed silk lutein extract
(10 and 20 mg/kg) and marigold lutein extract (20 mg/kg)
(Figure 3B). Furthermore, the magnitudes of the lymphocyte
proliferations were found to be similar in all of these lutein
extract treated groups.
Effect on cytokine production
The production of cytokines measured from the supernatants
of ConA-stimulated splenic cultures from mice fed lutein
extracts from silk cocoons or marigolds are illustrated in
Table 1. Mice fed 10 and 20 mg/kg silk lutein extract had
significantly increased (P < 0.05 and P < 0.01, respectively)
levels of IL-2 compared to the control mice. Elevated
levels of IFN-γ were also observed in the silk lutein extract
treated groups compared to the controls. In contrast, the
marigold lutein extract treated animals (10 and 20 mg/kg)
showed no differences in such cytokine production. No
treatment differences in the levels of IL-4 and IL-10 cytokines
were found after the 4-week period (data not shown).
Effect on specific antibody production
The effect of lutein extracts from silk cocoons or marigolds
on the production of specific antibodies was determined
by measuring anti-sheep erythrocyte antibody titers. As
shown in Figure 4, mice fed 10 or 20 mg/kg silk lutein
extract had significantly higher (P < 0.01) concentrations
of anti-sheep erythrocyte antibodies than the control mice.
Administration of marigold lutein extract at the dosages of
10 or 20 mg/kg did not result in elevated antibody titers.
Discussion
By assessing the key immune parameters in a BALB/c
mouse, an appropriate animal model for immunomodulatory
study of carotenoids [23], the present work demonstrated
that silk lutein extract significantly enhanced the immune
functions, both innate and adaptive arms. The antibody
response to a specific antigen (the sheep erythrocytes
herein) was clearly increased by the silk lutein extract while
the marigold lutein extract had no effect. For the specific
immune cell responses, a more complex picture emerges
with the yellow silk lutein extract. (i) For NK cells, the
enhancements of NK activity were apparent as early as
2 weeks after the initiation of lutein extract administration.
To our knowledge, this is the first time such lutein-
containing extract stimulation of NK cells has been identified.
Since NK cells are anti-tumor and antiviral hunter-killers,
our findings would suggest the potential for silk lutein
extract to augment NK cell surveillance. (ii) There was
an indication of an elevated percentage of total T cells,
which was reflected in the Th subset but not the Tc; and
**
**
Figure 1 Effect of silk lutein extract and marigold lutein extract on NK cell activity. Splenic cells were isolated from BALB/c mice fed lutein
extracts from silk cocoons or marigolds daily for 2 weeks and cultured with YAC-1 cell line at a ratio of 100: 1. After 20 hours in a 37°C and 5%
CO2 incubator, activity of NK cells was determined by MTT assay. Values represent means ± SEM. ** P < 0.01 compared to the control. SLT10,
SLT20; silk lutein extract 10 and 20 mg/kg groups, CLT10, CLT20; marigold lutein extract 10 and 20 mg/kg groups.
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levels were consistent with the lymphocyte stimulation.
Mitogen-induced lymphocyte proliferation is a powerful
indicator of adaptive immune functions. In the present
study, silk lutein extract strengthened the splenic*
A
B
Figure 2 Population changes in lymphocyte subsets in BALB/c mice f
isolated and labeled with fluorescently conjugated monoclonal antibodies
T cell markers CD3 (B), CD4 (C) and CD8 (D). The percentages of lymphocy
means ± SEM. * P < 0.05; ** P < 0.01 compared to the control. SLT10, SLT20lymphoproliferative response to ConA after 4 weeks
of administration. Such lymphocyte stimulation accords
with the increased CD3+ total T and CD4 + CD3+ Th
cell counts (Figure 2). Interestingly, only silk lutein
extract stimulated the production of IL-2. Therefore,**
C
D
ed silk lutein extract daily for 4 weeks. Splenic single cells were
specific for the mouse B cell markers CD21/35 (A), and the mouse
te subsets were quantitated by Flow cytometry. Values represent






Figure 3 Effects of silk lutein extract and marigold lutein extract on in vitro lymphocyte proliferation. Splenic cells were isolated from
BALB/c mice fed lutein extracts from silk cocoons or marigolds daily for 4 weeks and cultured in the presence of ConA (A) or LPS (B) at 37°C in a
5% CO2 incubator. After 20 hours, MTT assay was performed. Values represent means ± SEM. * P < 0.05; ** P < 0.01 compared to the control.
SLT10, SLT20; silk lutein extract 10 and 20 mg/kg groups, CLT10, CLT20; marigold lutein extract 10 and 20 mg/kg groups.
Table 1 In vitro cytokine production by splenic cells from
BALB/c mice fed with lutein extracts from silk cocoons or
marigolds daily for 4 weeks1
Treatment group Cytokine concentration (pg/ml)
IL-2 IFN-γ
Control 102.4 ± 25.4 1874.4 ± 304.0
SLT10 187.1 ± 18.9* 2568 .2 ± 233.5
SLT20 219.3 ± 11.9** 2265.6 ± 162.3
CLT10 97.5 ± 15.2 1037.8 ± 274.1
CLT20 97.5 ± 3.7 1787.8 ± 188.9
1 Splenic cells from mice fed with lutein extracts from silk cocoons or
marigolds were cultured with ConA at 37°C in 5% CO2 atmosphere. After
72 hours, supernatants were harvested and analyzed by sandwich ELISA.
Values represent means ± SEM. * P < 0.05; ** P < 0.01 compared to the control.
SLT10, SLT20; silk lutein extract 10 and 20 mg/kg groups, CLT10, CLT20;
marigold lutein extract 10 and 20 mg/kg groups.
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is likely attributable to the increases in total T and Th
subpopulations as well as to the production of IL-2. In
contrast, the marigold lutein extract in our study did not
alter the IL-2 level despite stimulated ConA-induced
lymphocyte proliferation. Similarly, increased lymphocyte
proliferation without IL-2 production has been reported
in cats, dogs and mice given marigold lutein extract
[8,11,12]. In this regard, increased lymphoproliferative response
may be mediated by the alterations in the expression
of surface molecules such as major histocompatibility
complex class II and IL-2 receptors, which are responsible
for antigen presentation and clonal expansion, respectively.
Taken together, the results of this study suggest that
silk lutein extract can enhance T cell functions, perhaps
differently from the marigold lutein extract.
Upon stimulation with sheep erythrocyte antigen, the
levels of anti-erythrocyte antibodies in plasma were
elevated in mice fed silk lutein extract. Although B
Figure 4 Levels of anti-sheep erythrocyte antibodies in BALB/c mice fed silk lutein extract or marigold lutein extract. A day after
cessation of treatment, mice were intraperitoneally injected with sheep erythrocytes as antigens. Second immunization was carried out on day
14 and blood samples were collected 7 days after the boost. Specific anti-sheep erythrocytes antibodies were determined by hemagglutination.
Values represent means ± SEM. ** P < 0.01 compared to the control. SLT10, SLT20; silk lutein extract 10 and 20 mg/kg groups, CLT 10, CLT 20;
marigold lutein extract 10 and 20 mg/kg groups.
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that the plasma cell functions may have been promoted.
The increased concentration of antigen-specific anti-
bodies would thus indicate the enhancement activity
of the silk lutein extract on humoral immune system
responding to pathogens and other foreign intrusions.
This finding is also of clinical significance because
silk lutein extract may serve as an adjuvant to help
stimulate the antibody production for routine vaccinations.
Discovery of new non-toxic adjuvants within the collections
of natural products has recently been put forward as an
urgent need for producing more efficacious vaccines [24].
While marigold lutein extract failed to show increased
antibody titers for mice in this study, such effects have
been observed in dogs [11] and cats [12]. Lutein given
to dogs and cats was pre-mixed with soybean oil [11] or
basal diet containing high fat [12] whereas the mice in
this study were fed only with a suspension of lutein.
Besides, lutein dosage, species of animals, challenged
antigens, and immunization schedules could also possibly
contribute to such differences.
The contents of lutein either from silk or marigold
extracts given to the animals herein were equivalent.
Nevertheless, there are certain differences in the silk and
marigold lutein extract preparation in this study. Lutein in
the silk extract was predominantly in a free unesterified
form whereas most commercial marigold lutein is present
in a diesterified form [25]. The silk, but not marigold,
extract also contained fats including free fatty acids plus
other insoluble wax materials. Until now, it is accepted
that in order to achieve its potential beneficial health
effects, the carotenoid lutein must be efficiently
absorbed and carried to its target tissues. Among dietary
factors that influence such bioavailability, fat seems to
exert the greatest impact on lutein absorption. This is
supported by the fact that the absorption efficiency of
lutein increases when the amount of fat in the diet
increases [26-30]. Available data have also demonstratedthat the bioavailability of lutein is much more sensitive
to a fat containing diet than other carotenoids such as
β-carotene. It was shown that 3 g fat were sufficient for
optimum absorption of α- and β-carotene whereas
higher amounts of fat (36 g) were required for optimum
absorption of lutein [26]. Recent studies where types of
fatty acids on lutein bioavailability was assessed have
also revealed that dietary fats rich in saturated fatty
acids lead to a higher bioavailability of lutein [31].
Regarding to this, the presence of fats in the silk
extract may promote solubilization and perhaps aid
stability of lutein, resulting in the efficient absorption
of lutein. Since palmitic and steric acids were the
predominant saturated fatty acids identified in the
silk extract, these fatty acids would also enhance such a
critical step for great bioavailability of lutein. Moreover,
the oleic acid in the silk extract may augment such
action as this fatty acid has also been reported to
modulate the absorption of dietary lutein [32]. Since the
unesterified form of lutein has greater bioavailability
[33-37], this could additionally explain the preferable
effects of the silk lutein extract, in comparison to
marigold lutein extract, in the present study. The fact
that lutein from the silkworm B. mori usually presents in a
protein-binding form [38,39] and that bound protein was
removed during the extraction process, there is a possibility
that the binding site of such lutein remains active and
preferentially acts on the target tissues, in different
manners to the esterified marigold lutein. Although
mechanisms responsible for this remain to be clarified,
the evidence described herein could explain, to a certain
degree, the differences of immune enhancing outcomes
between silk and marigold lutein extracts. The findings
in this study support the requirement of fats for lutein,
and highlight the importance of the sufficiently suitable
fats in silk extract preparation to facilitate absorption
before the lutein could efficiently exert its maximal
immune activity.
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In sum of the data, the present study demonstrated that
a package of the yellow silk cocoon extract containing
naturally occurring lutein and fats was capable of efficiently
enhancing both innate and adaptive immune functions.
Such silk lutein extract may prove superior to existing plant
lutein extract for strengthened immunity and consequent
health improvement.
Methods
Silk lutein extract preparation
Silk lutein extract was prepared according to the
method described in the patent with international
publication number WO 2012/091683 A1. Yellow cocoons
from the Nangnoi strain of Thai silkworms (Bombyx mori)
were first soaked in distilled water at a ratio of 1:30 and
then degummed at 121°C for 15 minutes to partially
remove glutinous silk protein sericin. After being
heated, degummed cocoons and degumming solution
were separated off, leaving degummed cocoons. Next,
the degummed cocoons were fourfold extracted with
30 ml of hexane/ethanol/ethyl acetate (3:2:1, v/v/v)
with 0.1% butylated hydroxytoluene (w/v) until colorless.
The resulting solution was collected and kept in an amber
glass sample bottle at 4°C. Then, it was partitioned into
non-aqueous phase and an aqueous phase by adding
100 ml of aqueous sodium chloride at 10% (w/v) into the
organic mixture solution. The supernatant was separated
from the aqueous phase and evaporated to dryness under
vacuum at temperature ≤ 35°C. The dried residue was
dissolved in hexane/ethyl acetate (3:1, v/v) to obtain a pre-
ferred volume of 5 to 10 ml and then filtered through a
0.45 μm PTFE syringe filter to obtain lutein extract. Analysis
using UV/VIS spectrophotometer (Libra S22, Biochrom Ltd.,
UK) revealed the absorption spectrum for lutein in the
resulting silk extract, as compared with the authentic lutein
standard (Figure 5A). Carotenoids and their compositions
in the silk extract were quantified by reversed-phase high-
performance liquid chromatography (HPLC; Agilent HP
1100 series). The silk extract contained lutein 5.4% w/w
and this represented a major constituent, accounting for
91.26%, of total carotenoids in such extract. The HPLC
chromatogram of the silk lutein extract, along with that
of the standard lutein, is shown in Figure 5B. As analyzed
by gas chromatography, the silk lutein extract also
contained free fatty acids 10.41% w/w while the remainder
was insoluble unidentified wax materials. The compositions
of fatty acids in the silk lutein extract are presented in
Table 2. Marigold lutein extract from Tagetes erecta flowers
was purchased from P.R. China through TTK Science
(Bangkok, Thailand). The marigold extract contained lutein
97.2%, as specified by the manufacturer. Analysis by liquid
chromatography-mass spectrometry (LC-MS) using
Ultraflex III TOF/TOF (Bruker Daltonik, GmbH)further confirmed identity of lutein in the silk and marigold
extracts. LC-MS analysis also displayed Maldi-TOF MS
spectra corresponding to kaempherol and quercetin in the
marigold extract whereas these flavonoids were not
detected in the silk lutein extract (data not shown).
Based on lutein concentration determined by HPLC,
the silk lutein extract solubilized in dimethylsulfoxide
(DMSO) was dissolved with 1% tween 80 in phosphate
buffered saline (PBS) pH 7.4 to achieve the desired
concentrations to be given to the animals. This working
lutein solution was prepared weekly and kept at −20°C
in sealed containers in the dark under nitrogen gas.
Preparation of the marigold lutein extract was performed
precisely as described for the silk lutein extract.
Animals and experimental design
Female BALB/c mice (7 weeks old; 20–23 g) were
obtained from the National Laboratory Animal Center,
Mahidol University, Thailand. Animals were housed in
polycarbonate cages maintained at 25 ± 1°C with a 12-h
dark: light cycle and had free access to sterile water and
standard mouse diet (CP Company, Thailand; Table 3).
Animal procedures were reviewed and approved by
the Animal Research Ethics Committee of Naresuan
University, Thailand (Permit Number: 52040007). All
animal experiments were conducted in accordance
with the institutional guidelines for the care and use
of laboratory animals. The mice were randomly assigned to
five groups of five animals each and were orally administered
via a feeding tube with either: (1) vehicle (1% Tween 80 in
PBS pH 7.4; Controls); (2) 10 mg/kg body weight of silk
lutein extract (SLT10); (3) 20 mg/kg silk lutein extract
(SLT20); (4) 10 mg/kg commercial lutein marigold extract
(CLT10; P.R. China); and (5) 20 mg/kg commercial lutein
marigold extract (CLT20). These dosages were administered
once daily for a period of 4 weeks. Animal body weights
were recorded weekly and routine clinical observations
were carried out throughout the experiments.
Five mice in each group were humanely killed by
intraperitoneal injection with an overdose of pentobarbital
sodium (NembutalR, Ceva Sante Animale, France; 40–50 mg/kg
body weight) on week 2 (for assessment of natural killer cell
activity) and week 4 (for other immune parameters) after the
initial lutein extract administration. The spleens and thymus
were removed and weighed immediately. Their indices were
expressed as 100× spleen or thymus weight/ body weight.
Splenic single cell preparation
After being removed, the spleens were aseptically saved in
a PCM buffer prepared with sterile PBS pH 7.4 containing
7 × 10−4 M CaCl2, 5 × 10
−4 M MgCl2, 5% (v/v) fetal bovine
serum (Gibco, South America), 100 U/ml penicillin, and
100 μg/ml streptomycin (PAA, Pasching, Austria). Single
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Figure 5 Fingerprints of silk lutein extract, marigold lutein extract and standard lutein (Sigma). (A) UV/VIS absorption spectra (B) HPLC
chromatograms at 445 nm. HPLC was conducted using a LiChrospher®100 reversed-phase C30 column as stationary and acetonitrile/methanol
(9:1, v/v) and ethyl acetate as mobile phases. Peaks: 1, (13-Z)-lutein; 2, (13′-Z)-lutein; 3, (all-E)-lutein; 4, (9-Z)-lutein and 5, (9′-Z)-lutein.
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Table 2 Fatty acid compositions of silk lutein extract1
Fatty acid g/g of fat % Fatty acid g/g of fat %
Capric acid 0.0005 0.05 Alpha Linolenic acid 0.0056 0.56
Lauric acid 0.0010 0.10 Arachidic 0.0027 0.27
Myristic acid 0.0013 0.13 cis-11-Eicosenoic acid 0.0002 0.02
Pentadecanoic acid 0.0002 0.02 c9, t11 0.0002 0.02
Palmitic acid 0.0197 1.97 c9, c11 0.0006 0.06
Palmitoleic acid 0.0009 0.09 cis-11,14-Eicosedienoic acid 0.0001 0.01
Stearic acid 0.0161 1.61 cis-8,11,14-Eicosatrienoic acid 0.0037 0.37
Elaidic 0.0007 0.07 Behenic 0.0018 0.18
Oleic acid 0.0290 2.90 cis-4,7,10,13,1 6,19-Docosahexaenoic acid 0.0017 0.17
Linoleic acid 0.0137 1.37 Erucic 0.0015 0.15
Gamma-Linolenic acid 0.0005 0.05 Lignoceric 0.0024 0.24
1 Fatty acid compositions were analyzed by gas chromatography (Hewlett Packard GC system HP6890 A; Hewlett Packard, PA) equipped with a 100 m × 0.25 mm
fused silica capillary column (SP2560, Supelco Inc, Bellefonte, PA). Injector and detector temperatures were set at 250°C. The column temperature was kept at 4°C
for 4 min, then increased at 13°C/min to 175°C and held at 175°C for 7 min, then increased at 4°C/min to 215°C and held at 215°C for 17 min.
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NH4Cl pH 7.65, and the resulting cell suspensions were
washed twice with a PCM buffer by centrifugation. Cell
pellets were finally resuspended with RPMI-1640 (PAA)
containing 10% (v/v) fetal bovine serum, 0.01 M HEPES
pH 7.4, 5 × 10−5 M β-mercaptoethanol (BioRad, Hercules,
CA), 2 mM L-glutamine, 100 U/ml penicillin and 100 μg/ml
streptomycin. The viability of the splenic cells was determined
by trypan blue dye exclusion using a hemocytometer.
Natural killer cell activity
Splenic natural killer (NK) cell activity was evaluated by
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay as previously described [40,41]Table 3 Nutritional composition of mice feed
Component Amount Component Amount
Moisture 12% Vitamin A 20,000 i.u./kg
Crude protein 24% Vitamin D 4,000 i.u./kg
Fat 4.5% Vitamin E 100 mg/kg
Fiber 5% Vitamin K 5 mg/kg
Calcium 1% Vitamin B1 20 mg/kg
Phosphorus 0.9% Vitamin B2 20 mg/kg
Sodium 0.2% Vitamin B6 20 mg/kg
Potassium 1.17% Vitamin B12 0.036 mg/kg
Magnesium 0.23% Niacin 100 mg/kg
Manganese 171 p.p.m. Folic acid 6 mg/kg
Copper 22 p.p.m. Biotin 0.4 mg/kg
Zinc 100 p.p.m. Pantothenic acid 60 mg/kg
Iron 180 p.p.m. Choline chloride 1,500 mg/kg
Cobalt 1.82 p.p.m. Metabolizable energy 3,040 kcal/kg
Potassium iodide 1 p.p.m.
Selenium 0.1 p.p.m.with few modifications. Briefly, splenic cells (effector cells),
prepared as described above, and YAC-1 cells (target cells;
American Type Culture Collection, Manassas, VA) were
incubated together in 96-well flat-bottom plates (NuncR)
(effector: target ratio of 100:1) with a total volume of
200 μl in each well. The plates were incubated at 37°C in a
humidified 5% CO2 atmosphere. After 20 hours, 100 μl of
the culture supernatants were removed and 40 μl of MTT
(5 mg/ml; Sigma, St. Louis, MO) was added. After an
additional 3 hours of incubation, the plates were subjected
to an MTT assay [42]. Control wells contained either
effector or target cells alone, and all tests were performed in
triplicate. The optical density (OD) at 540 nm was determined
by using a microplate spectrophotometer (Labsystem iEM
Reader MF). The percentage of NK cell cytotoxic activity was
calculated according to the formula: {1- [(OD test –
OD effector cell control) / OD target cell control]} × 100.Splenic lymphocyte subpopulations
The percentages of lymphocyte subpopulations in the
spleen were quantified by Flow cytometry. Splenic single
cell suspensions (4 × 105 cells) were stained for 30 minutes
on ice with fluorescently conjugated antibodies specific for
the mouse T cell markers CD3, CD4 and CD8, and for the
mouse B cell markers CD21/35. Fluorescein isothiocyanate
conjugated anti-mouse CD3e (clone eBio500A2),
phycoerythrin (PE) conjugated anti-mouse CD4 (clone
RM4-5), PE conjugated anti-mouse CD8a (clone 53–6.7),
and PE conjugated anti-mouse CD21/CD35 (clone
eBio8D9) were all purchased from eBioscience (San Diego,
CA). Appropriate isotype-matched antibodies were used as
controls for background staining. Stained cells were washed
twice with cold-PBS containing 2% fetal bovine serum and
then fixed with 1% paraformaldehyde. Cells were then
analyzed with a Becton Dickinson FACScalibur and
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5,000 events were acquired for each analysis.Mitogen-induced lymphocyte proliferation
The proliferation of splenic lymphocytes in response to
T and B cell mitogens was determined by MTT assay
[42]. A total of 2 × 105 splenic cells were cultured in
flat-bottom 96-well plates (NuncR) in the presence or
absence of Concanavalin A (ConA, 0.5 μg/ml; Sigma) or
lipopolysaccharide (LPS, 2.5 μg/ml; Sigma) and incubated
at 37°C in a 5% CO2 atmosphere. After 48 hours, 20 μl of
MTT (5 mg/ml) was added and the plates were incubated
for another 4 hours. Supernatant in each well was
discarded, and 100 μl of DMSO was added to dissolve
the formazan crystals. The OD at 540 nm of each well was
measured on a microplate spectrophotometer (Labsystem
iEM Reader MF). All assay tests were done in triplicate.Cytokine production
The production of regulatory cytokines caused by splenic
lymphocytes was determined by sandwich enzyme-linked
immunosorbent assay (ELISA) using Ready-Set-Go for
mouse IL-2, IFN-γ, IL-4 and IL-10 (eBioscience). All assay
procedures were performed according to the manufacturers’
instructions. A total of 2 × 105 splenic cells were cultured in
flat-bottom 96-well plates (NuncR) in the presence of Con
A (0.5 μg/ml for interferon-γ (IFN-γ), interleukin-4 (IL-4)
and interleulin-10 (IL-10), and 2.5 μg/ml for interleukin-2
(IL-2). After incubating the cells at 37°C in 5% CO2
atmosphere for 72 hours, the cultured supernatants
were collected and stored at −20°C until assayed. The
detection limits were 2, 15, 4, and 30 pg/ml for IL-2, IFN-γ,
IL-4, and IL-10, respectively.In vivo antibody response
Humoral immune response was assessed through an
immunization protocol with sheep erythrocytes as antigens.
A day after ceasing treatment, the mice were intraperitoneally
injected with 2 × 108 erythrocytes in 0.2 ml saline solution.
A second immunization was carried out on day 14 and
blood samples were collected 7 days after the boost. Specific
anti-sheep erythrocytes antibodies were determined by
hemagglutination. The reciprocal serum dilution with ≥ 50%
agglutination was considered to be the titer.Statistical analysis
Data are expressed as mean ± SEM. The differences
among groups were evaluated by one-way analysis of
variance (ANOVA), followed by Tukey’s Honestly Significant
Difference test. All statistical analyses were performed with
SPSS version 11.5 (SPSS Inc., Chicago, IL). Differences
were considered to be significant at P < 0.05.Competing interests
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